The new measures, announced by President Biden at the White House, will apply to about two-thirds of American employees, who work for businesses with more than 100 employees.
Most federal employees will have to be vaccinated, while large employers will have to require their employees to be vaccinated or tested for Covid-19 every week.
The US Department of Labor’s Occupational Safety and Health Administration (OSHA) will issue a rule requiring private companies to implement the new rule in the coming weeks. Cases of non-compliance can face fines of up to $14,000 per violation Reuters.
As part of the new strategy, the Biden administration will also require vaccinations for more than 17 million healthcare workers at hospitals and other organizations participating in the Health Care and Medicaid social program. for disadvantaged, disabled and elderly citizens.
US President Joe Biden on September 9 announced a new strategy to prevent the spread of the Delta variant. Photo: Reuters
Previously, President Biden required federal employees to be vaccinated or tested. Currently, this group has 75 days to get vaccinated if it doesn’t want to be fired, with few exceptions.
“We have been patient. But our patience is running out. We are all paying the price for those who do not get vaccinated,” – President Biden emphasized.
Along with the new policies, President Biden’s remarks are by far the toughest moves to spur vaccine skepticism amid a surge in infections and hospitalizations because of the Delta variant.
Newspaper The New York Times on September 9 said the US is recording an increase of about 1,500 deaths per day, 5 times more than since the beginning of August. The US averages about 152,000 cases of Covid-19 every day in the past 2 weeks.
According to data from the Centers for Disease Control and Prevention (CDC), the full vaccination rate in this country is only 53% so far.
The number of hospitalizations and deaths from Covid-19 is increasing sharply in the US. Photo: AP
China shows off its first domestic mRNA vaccine
China’s first mRNA-based Covid-19 vaccine will be mass-produced from October, with 200 million doses per year.
Follow Global Times (China), the above product is called ARCoVax; co-developed by the Chinese Academy of Military Medical Sciences, Suzhou Abogen Company and Yunnan Walvax Company. Large-scale production will begin in Yuxi town, Yunnan province, China next month.
Compared with mRNA vaccines developed by the US and Germany, ARCoVax is claimed by Chinese media to be “much safer” thanks to a more precise antigen selection, with a higher amount of neutralizing antibodies produced.
China’s first mRNA-based Covid-19 vaccine will be mass-produced from October. Photo: Global Times